Delivery Order SPE2DB24D9155-SPE2DB24FHZFG

Award Date 8/8/24
Potential Completion Date 8/29/24
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $13,844.40, is for the delivery of 100-unit vials of Botox to fulfill the recurring medical supply needs of military health facilities worldwide. The contract is part of DMS Pharmaceutical Group's broader $499,999,999 indefinite delivery contract (IDC) with the DLA...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,836.20 contract is for the delivery of 200-unit vials of Botox medication to support the recurring medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $48,455.40, is for the delivery of 4,565,988,703 vials of Botox 100 unit injections. The period of performance runs through October 21, 2024. This delivery order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the DLA, valued at up to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $15,607.70 contract is for the supply of 200-unit vials of Botox to support the recurring medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $10,555.92 contract is for the delivery of Botox 100 unit vials to support the medical supply needs of military health facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue firm fixed-price delivery orders...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract, valued at $59,676.50, is for the delivery of 200-unit vials of Botox to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue delivery orders for a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $11,564.25 contract is for the delivery of 100-unit vials of Botox medication to support the medical supply needs of military healthcare facilities. The contract is not associated with a set-aside designation. DMS Pharmaceutical Group Inc. also holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $11,017.20 contract is for the delivery of 200-unit vials of Botox, a specialized pharmaceutical product, to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $6,356.60, covers the supply of 200-unit vials of Botox to support the recurring pharmaceutical needs of military medical facilities. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $16,613.28, is for the supply of 100-unit vials of Botox to support the recurring medical supply needs of military health facilities. The delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, that allows the...
  • SPE2DB24D9155
    Indefinite Delivery Contract
  • SPE2DB24D9155-SPE2DB24FHZFG
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $11,075.52, is for the delivery of 100-unit vials of Botox to support the medical supply needs of military health facilities.

The contract is part of DMS Pharmaceutical Group's broader indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999 and running through December 31, 2025. This IDC allows the DLA to issue firm fixed-price delivery orders for a wide range of pharmaceutical products, from common medications to specialized drugs and medical supplies, to fulfill the recurring medical requirements of Department of Defense healthcare facilities worldwide.

DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the diverse medical needs of military personnel and their dependents.

Generated 11/7/24, 9:16 AM